Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$ADMA Class Alert: ADMA Biologics Investors have Rights in Filed Securities Fraud Class Action - Contact BFA Law if You Suffered Losses

accessnewswire.com
ADMA

$RBLX Class Alert: Roblox Investors Have Rights in Filed Securities Fraud Class Action - Contact BFA Law if You Suffered Losses

accessnewswire.com
RBLX

$SEM Class Alert: Select Medical Shareholders Have Rights in Pending Investigation Into The Board Over The Announced Acquisition - Contact BFA Law if You Hold Shares

accessnewswire.com
SEM

$MAX Class Alert: MediaAlpha Shareholders have Rights in Pending Investigation into the Board Over the FTC Settlement - Contact BFA Law if You Hold Shares

accessnewswire.com
MAX

$GRAL Class Alert: GRAIL Investors have Rights in Filed Securities Fraud Class Action - Contact BFA Law if You Suffered Losses

accessnewswire.com
GRAL

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

globenewswire.com
CLDX

RiderNav presenta sus pantallas inteligentes de 7 pulgadas para motocicletas en el Mid-Summer Riding Festival

prnewswire.com
HOG HMC AAPL

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

globenewswire.com
LEGN

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

prnewswire.com
LLY

Bitmine Immersion Technologies gibt erste Dividendenausschüttung und Notierung der Vorzugsaktien der Serie A an der NYSE bekannt

prnewswire.com
BMNP BMNR
View all news →